NCT00882336

European Study of Cardiovascular Risk

Epidemiological Study of European Cardiovascular Risk Patients: Disease Prevention and Management in Usual Daily Practice

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 7,200 (estimated)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries. The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office. Study variables will be measured: * By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication. * By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment. * By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured. * CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.

Conditions

• Cardiovascular Risk Factors
• Hyperlipidemia
• Hypertension
• Diabetes
• Obesity
• Smoking

Timeline

• Start date: 2009-05-01
• Completion: 2009-10-01
• First posted: 2009-04-16
• Last updated: 2009-10-29

Locations

775 sites across 12 countries: Austria, Belgium, France, Germany, Greece, Norway, Russia, Spain, Sweden, Switzerland, Turkey (Türkiye), United Kingdom